# Engineering Pseudomonas taiwanensis for efficient chorismate-based production of mono- and dihydroxybenzoates

## TL;DR

Scientists engineered a bacterium to efficiently produce various aromatic compounds from renewable sources, offering a sustainable alternative to traditional fossil-based methods.

## Contribution

The study introduces a modified Pseudomonas taiwanensis strain that enhances the production of hydroxybenzoates without causing metabolic deficiencies.

## Key findings

- Modifications to the pheA gene increased the production of 2-hydroxy- and 2,3-dihydroxybenzoate without causing auxotrophy.
- Replacing the native pheA gene with the Escherichia coli homolog improved 4-hydroxybenzoate production to 3.59 mM with a 20.9% yield from glucose.
- The impact of pheA modifications varied depending on the production module, highlighting the interplay with host metabolism.

## Abstract

Aromatics have many important applications in modern society but are traditionally produced in non-sustainable processes from fossil resources. Whole-cell biocatalysis bears great potential to provide a variety of aromatics from renewable carbon sources, thereby offering a more sustainable alternative. In this context, chorismate, the end product of the shikimate pathway, is an important biosynthetic hub compound that serves as precursor of a multitude of industrially relevant aromatics. Here, we screened several pathways for chorismate-derived bioproduction of five different mono- and dihydroxybenzoates in tyrosine-overproducing Pseudomonas taiwanensis GRC3Δ5-TYR1. Subsequently, twelve different modifications targeting the bifunctional chorismate mutase/prephenate dehydratase PheA were screened to reduce flux from chorismate to phenylalanine and tyrosine, thereby further enhancing the production of 2-hydroxy- and 2,3-dihydroxybenzoate without causing an auxotrophy. An auxotrophic ΔpheA strain served as benchmark control. Most promising modifications were subsequently also evaluated for 3-hydroxy-, 4-hydroxy- and 2,5-dihydroxybenzoate production demonstrating increased yields. Replacing the native pheA gene with the unmodified homolog from Escherichia coli was the most beneficial, enabling an increased production of up to 38.2% when combined with attTn7::P14g-SmCH-IV. With this modification, the highest production was achieved for 4-hydroxybenzoate resulting in titers of 3.59 mM and a yield of 20.9% (Cmol/Cmol) from glucose. However, the impact of the respective pheA modification varies with the applied production module, further emphasizing the strong interplay with the production host's metabolism.

Image 1

•Chorismate-derived hydroxybenzoate production in P. taiwanensis CHOR platform.•Mutations in pheA improved production without causing auxotrophies.•High-yield production of five different hydroxybenzoates from glucose and glycerol.

Chorismate-derived hydroxybenzoate production in P. taiwanensis CHOR platform.

Mutations in pheA improved production without causing auxotrophies.

High-yield production of five different hydroxybenzoates from glucose and glycerol.